AcroMetrix

Benicia, United States Founded: 1999 • Age: 27 yrs Acquired By Life Technologies
Provider of molecular products for research and therapeutics uses

About AcroMetrix

AcroMetrix is a Healthcare company based in Benicia (United States) founded in 1999, and was acquired by Life Technologies in February 2010. Provider of molecular products for research and therapeutics uses. Its chief executive, as recorded, is Marc Casper. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is ACROMETRIX LLC. Its competitors include GenScript, Teknova and Meridian Bioscience; 1 of its 3 listed competitors has raised funding.

Company details

AcroMetrix provides molecular products for research and therapeutic uses. The company offers molecular products that include controls and monitoring of assays for clinical and research laboratories, blood centers, and IVD manufacturers. It offers products for oncology, transplant, infectious disease testing, blood screening solutions, and development of custom QC solutions among others.

  • Headquarters Benicia, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website acrometrix.com
  • Acquired by Life Technologies (Feb 2010)
  • Legal Name Acrometrix Llc
Key Metrics

Investors in AcroMetrix

AcroMetrix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Life Technologies.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Tools and technologies for biotech and biopharma research were supplied.
1983lifetechnologies.comCarlsbad, United States
Premium access

Investor details for AcroMetrix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of AcroMetrix

1 people are tracked at AcroMetrix (1 in leadership).

NameRoleGroup
Marc Casper
CEO & PresidentLeadership
Premium access

Complete people profiles for AcroMetrix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of AcroMetrix

2 dated milestones of AcroMetrix across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded AcroMetrix is founded.
  2. Exit Acquired by Life Technologies.

Competitors of AcroMetrix

AcroMetrix has 3 listed competitors in our database, 1 of them funded. They include GenScript, Teknova and Meridian Bioscience.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
teknova.com1996Hollister, United States290
Molecular biology reagents and kits are supplied for research applications.
meridianbioscience.com1976Ohio, United States
Molecular diagnostic device and kits
Premium access

Detailed competitors of AcroMetrix

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as AcroMetrix (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about AcroMetrix

AcroMetrix was founded in 1999.

AcroMetrix is headquartered in Benicia, United States. It is registered at Benicia, California, United States.

Marc Casper is the CEO of AcroMetrix, as recorded in our data.

AcroMetrix provides molecular products for research and therapeutic uses. The company offers molecular products that include controls and monitoring of assays for clinical and research laboratories, blood centers, and IVD manufacturers. It offers products for oncology, transplant, infectious disease testing, blood screening solutions, and development of custom QC solutions among others.

AcroMetrix's top competitors include Meridian Bioscience, GenScript and Teknova.

AcroMetrix has 1 investor. Key investors include Life Technologies.

AcroMetrix operates through Acrometrix Llc.

Yes. AcroMetrix was acquired by Life Technologies in February 2010.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available